School of Medicine
Showing 12,101-12,200 of 13,029 Results
-
Victoria Ward
Clinical Associate Professor, Pediatrics
Current Research and Scholarly InterestsGlobal child health, digital health, preterm birth, human trafficking
-
Roger Warnke
Ronald F. Dorfman, M.B.B.ch., FRCPath, Professor in Hematopathology, Emeritus
Current Research and Scholarly InterestsAs an Emeritus Professor, I no longer have a research laboratory and am now fully retired.
-
Lianna Wat
Postdoctoral Scholar, Neurobiology
BioLianna obtained her Ph.D. in Cell and Developmental Biology in Dr. Elizabeth Rideout’s lab at the University of British Columbia in 2021 where she studied the sex-specific regulation of fat metabolism using Drosophila as a model system. Lianna is bringing her expertise on sex differences and fat metabolism to the Svensson lab where she is interested in understanding in discovering secreted metabolic effectors that regulate male-female differences in energy metabolism and the development of metabolic disease
-
Jenli Dawn Waters, MD
Clinical Assistant Professor, Neurosurgery
BioDr. Waters is a board-certified, fellowship-trained neurosurgeon with the Neurosurgery Program at Stanford Health Care. She is also a clinical assistant professor of neurosurgery in the Department of Neurosurgery at Stanford University School of Medicine.
Dr. Waters specializes in treating a wide range of spinal conditions. These treatments include surgery to relieve numbness or pain related to pressure on the spinal cord and procedures to repair or stabilize the spinal column (spine fusion). Her areas of expertise also include diagnosis and treatment of traumatic brain injury and brain and spinal cancers.
Dr. Waters’ research experience includes helping to develop effective strategies for diagnosing
and treating patients with different neurological cancers, including glioblastomas. As a subspecialty medical expert for spine and neurosurgery, she successfully advocated for insurance coverage of state-of-the-art, minimally invasive approaches to treating epilepsy and brain tumors.
Dr. Waters has published her work in peer-reviewed journals, including the Journal of Neurosurgery and the Journal of Neuro-Oncology. She has also authored and co-authored chapters in numerous books describing neurosurgical techniques and the diagnosis and treatment of various neurological conditions, including brain and spinal cord tumors.
Dr. Waters is a member of the Congress of Neurological Surgeons. -
Ronald D. Watkins
Senior Research Engineer, Rad/Radiological Sciences Laboratory
Current Role at StanfordMy current position is Senior Research Associate in the Radiological Sciences Laboratory and the Molecular Imaging Laboratory in the Department of Radiology at Stanford School of Medicine. I provide hardware, systems, and general technical support for a large group of Faculty members and many students and post docs in the development of advanced medical imaging, metabolic imaging and image-guided interventions. My training background is primarily in RF and electrical engineering. I have spent more than 25 years in the commercial diagnostic imaging industry. Most of the projects I am currently working on involve instrumentation for metabolic imaging using magnetic deuterium imaging. I am also involved in the development of Hybrid systems that combine Positron Emission Tomography and Magnetic Resonance imaging. Other projects I am involved in use focused ultrasound for neuro-stimulation or drug delivery via blood brain barrier. I also provide RF coil design and support for small animal imaging and various research studies. I have ongoing collaborations with many other medical research institutes and Universities around the world. I currently have 45 issued US patents, and 100 pear reviewed publications.
-
Erin Watson, PsyD, ABPP
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
BioDr. Erin Watson is a board-certified clinical health psychologist and Clinical Associate Professor in the Division of Gastroenterology & Hepatology at Stanford University School of Medicine. She is a member of Stanford Health Care’s GI Behavioral Medicine program, where she specializes in the intersection of psychological health, behavioral science, and gastrointestinal and liver disease.
Dr. Watson’s clinical work focuses on helping patients navigate the emotional, behavioral, and lifestyle factors that influence medical illness. Her areas of expertise include health anxiety, stress and symptom management, health-behavior change, adjustment to chronic conditions, and the emerging specialty of psycho-hepatology. She uses practical, evidence-based approaches—including cognitive behavioral therapy, acceptance and commitment therapy, mindfulness-based interventions, and motivational interviewing—with lifestyle-medicine strategies to support long-term health and resilience. Her goal is to help patients feel more informed, supported, and empowered throughout their care.
In addition to her clinical work, Dr. Watson is engaged in research to advance behavioral treatments for chronic pain and develop new psychological interventions for individuals living with chronic liver disease. She is a co-investigator on a National Institutes of Health–funded study examining effective treatment options for veterans with chronic pain and addiction. Her scholarly work has been published in peer-reviewed journals and presented at regional and national conferences, including annual meetings of the American Psychological Association.
Dr. Watson is a Fellow of the American Academy of Clinical Health Psychology and a member of the American Psychological Association, the Society for Health Psychology (Division 38), the Society of Behavioral Medicine, the American Association for the Study of Liver Diseases, and the Rome Foundation. -
Kathleen Watson
Instructor, Psychiatry and Behavioral Sciences
BioKathleen Watson, Ph.D., currently serves as an instructor at Stanford University School of Medicine, specializing in Epidemiology and Clinical Research. She co-founded Microclinic International in 2007, where she served as Chief Operating Officer until 2012, focusing on socially-based health interventions for underserved communities.
Dr. Watson's research encompasses various aspects of mental health and metabolism. She investigates the connection between insulin resistance and depression, using computational psychiatry to uncover insights into the interplay of metabolic factors in mental well-being. Additionally, her exploration of cognitive aging examines how metabolic alterations might impact cognitive decline and related disorders. Furthermore, her research in proteomics aims to identify potential biomarkers for severe major depressive disorder. Dr. Watson has recently become a part of the Stanford Autism Center for Excellence Data Core, where she works under the guidance of Dr. Booil Jo. -
Robert Waymouth
Robert Eckles Swain Professor of Chemistry and Professor, by courtesy, of Chemical Engineering
BioRobert Eckles Swain Professor in Chemistry Robert Waymouth investigates new catalytic strategies to create useful new molecules, including bioactive polymers, synthetic fuels, and sustainable plastics. In one such breakthrough, Professor Waymouth and Professor Wender developed a new class of gene delivery agents.
Born in 1960 in Warner Robins, Georgia, Robert Waymouth studied chemistry and mathematics at Washington and Lee University in Lexington, Virginia (B.S. and B.A., respectively, both summa cum laude, 1982). He developed an interest in synthetic and mechanistic organometallic chemistry during his doctoral studies in chemistry at the California Institute of Technology under Professor R.H. Grubbs (Ph.D., 1987). His postdoctoral research with Professor Piero Pino at the Institut fur Polymere, ETH Zurich, Switzerland, focused on catalytic hydrogenation with chiral metallocene catalysts. He joined the Stanford University faculty as assistant professor in 1988, becoming full professor in 1997 and in 2000 the Robert Eckles Swain Professor of Chemistry.
Today, the Waymouth Group applies mechanistic principles to develop new concepts in catalysis, with particular focus on the development of organometallic and organic catalysts for the synthesis of complex macromolecular architectures. In organometallic catalysis, the group devised a highly selective alcohol oxidation catalyst that selectively oxidizes unprotected polyols and carbohydrates to alpha-hyroxyketones. In collaboration with Dr. James Hedrick of IBM, we have developed a platform of highly active organic catalysts and continuous flow reactors that provide access to polymer architectures that are difficult to access by conventional approaches.
The Waymouth group has devised selective organocatalytic strategies for the synthesis of functional degradable polymers and oligomers that function as "molecular transporters" to deliver genes, drugs and probes into cells and live animals. These advances led to the joint discovery with the Wender group of a general, safe, and remarkably effective concept for RNA delivery based on a new class of synthetic cationic materials, Charge-Altering Releasable Transporters (CARTs). This technology has been shown to be effective for mRNA based cancer vaccines. -
Annika M. Weber
Postdoctoral Scholar, Gastroenterology
BioAnnika is a postdoctoral scholar in the Spencer Lab studying how gut microbes metabolize prebiotic fibers to produce bioactive metabolites linked to lowering disease risk. She holds an MS in Human Nutrition from the University of Sheffield and a PhD in Food Science and Human Nutrition from Colorado State University. Her work integrates multi-omic approaches to map diet-microbe-metabolite relationships. Annika aims to translate these mechanistic insights into microbiome-informed dietary strategies for reducing chronic diseases.
-
Kenneth Weber, DC, PhD
Assistant Professor (Research) of Anesthesiology, Perioperative and Pain Medicine (Adult Pain) and, by courtesy, of Neurosurgery (Adult Neurosurgery) and of Radiology (Neuroimaging and Neurointervention)
BioDr. Weber directs the Neuromuscular Insight Lab. Dr. Weber's research seeks to develop quantitative markers of sensory and motor function, including pain, using machine-learning and advanced brain, spinal cord, and musculoskeletal magnetic resonance imaging. Dr. Weber aims to use these techniques to better understand the neuropathology of neurological and musculoskeletal conditions and discover more effective treatments and preventative strategies.
-
Whitney Weber
Postdoctoral Scholar, Infectious Diseases
BioWhitney is a postdoctoral scholar in the laboratory of Dr. Joelle Rosser at Stanford University investigating the impacts of climate change on arbovirus infection acquisition in a mother-child human cohort in Indonesia. She recently completed her PhD in 2024 focused in viral immunology in the laboratory of Dr. Daniel Streblow at Oregon Health and Science University. She has 4+ years of experience focused in antibody-mediated immunity to emerging pathogenic alphaviruses. Her dissertation research focused on characterizing cross-reactive immunity in the context of alphavirus infection and vaccination in an effort to develop cross-protective alphavirus vaccines. Her post-bacc work included 2+ years of research experience in HIV immunology studying the mechanism of HIV cure and evaluating therapeutics in NHP. Her long-term research and career interests are rooted in studying the mechanisms of viral emergence, viral surveillance and seroprevalence in various hosts, identifying cross-reactive immune responses, and developing multivalent vaccine approaches for emerging viruses.
-
Mike Tzuhen Wei
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioDr. Wei was born and raised in Taipei, Taiwan. He went to Stanford for his undergraduate studies in Biology and earned his medical degree at Weill Cornell Medical College. Unable to stay far from the Bay Area, he returned to Stanford where he completed his residency in internal medicine and subsequently his fellowship in gastroenterology. Dr. Wei has specific interests in colorectal cancer and Barrett’s esophagus surveillance as well as reflux diagnosis and management. He has an interest in endoscopic resection of large polyps and had received training under Dr. Shai Friedland, a world expert in this field. Dr. Wei work focuses on evaluating new tools, technologies and techniques in gastrointestinal cancer surveillance and management. He has been involved in running several trials in endoscopic management of polyps and evaluating artificial intelligence applications in gastroenterology. His work has been published in American Journal of Gastroenterology, Gastrointestinal Endoscopy, Clinical Endoscopy, VideoGIE, and Digestive Diseases and Sciences. He was formerly an Associate Editor for the ACG Case Report Journal (2020-2022) and was on the Board of the Northern California Society of Clinical Gastroenterology. When not in clinic or in endoscopy, Dr. Wei enjoys spending time with his family. He and his family enjoy traveling and exploring new restaurants.
-
Ruolun Wei
Postdoctoral Scholar, Neurosurgery
BioRuolun Wei, MD, PhD, is a postdoctoral scholar in the Department of Neurosurgery at Stanford University. Dr. Wei’s work centers on neuro-oncology, with particular emphasis on brain tumor recurrence, treatment resistance, and tumor metabolism. He is also a board-certified neurosurgeon, currently focusing on full-time research. His research aims to bridge the gap between clinical practice and laboratory investigation, conducting translational research that moves from bedside to bench and back to bedside to improve therapeutic outcomes for patients with malignant brain tumors.
-
Tan Wei Ting
Affiliate, Neurosurgery
BioWei Ting graduated from University Malaya under the Department of Biomedical Engineering (Bachelor & Master's).Apart from multidisciplinary (tissue engineering, medical imaging, computational biology) research experience, she has worked in startups, industry, clinics, and medical centres with exposure to rehabilitation robotics, TCM in fertility, and clinical trials.
Her past undergraduate research experience includes
1. Dr Belinda Murphy’s Tissue Engineering Lab to assist in cell culturing and cytotoxicity testing
2. Asian Cardiac Laboratory under Dr Lim Einly for medical imaging-based investigation of flow energetics and vortex parameters in heart attack patients
For master's research, funded under Newton Advanced Fellowship in collaboration with Imperial College London’s Prof Xu group and UTM's Dr Mohd Jamil’s group.
1. Research focus: investigating the risk factor of distal stent induced new entry in aortic dissection patients using both simplified and patient-specific models.
2. Presented in local and international conference, published peer review studies and has reviewed paper relevant to the project.
With curiosity for knowledge, arts, philosophy, and the sciences, she often diving into new fields, moves across disciplines, and combines several areas of knowledge. She gained both lab-based and computational skills, for example: bioinformatics, pharmacokinetic modelling, cell staining, confocal microscopy, FRET cell transfection, live cell imaging, image processing, high-performance computing, quantum algorithms, etc. At MSU, she is part of the Tau Beta Pi National Honor Society and Cloud Computing Foundations (CCF) Program. For the cloud program, her interest is to apply hybrid computational quantum-classical framework for small molecule drug development.
Wei Ting has been active in learning more about different facets of medicine and often engages with researchers and physicians. She has gained familiarity with neurological disease (e.g. autism, Parkinson's, and Alzheimer's) from different perspectives (e.g., rehabilitation robotics, brain simulation, and psychiatry). She is invited to join the Neurobehavior and Neuroscience Methods Workshop (SPrINT/Stanford) in 2026. -
Martin Weik
Affiliate, Structural Biology
Visiting Scholar, Structural BiologyBioMartin Weik is a CEA research director at the Institut de Biologie Structurale in Grenoble, France. He leads the “Structural Protein Dynamics” research team and chairs the “Dynamics and Kinetics of Molecular Processes” group. His work focuses on the dynamics of proteins — how they move and change shape over time — and how these dynamics relate to their function. Light-sensitive proteins (photoreceptors and fluorescent proteins, for example) are studied using a variety of experimental biophysical methods, including time-resolved serial crystallography at X-ray free electron lasers and synchrotrons. His other research interests include investigating how hydration water (i.e. water molecules surrounding proteins) couples to the dynamics of proteins, fibrous aggregates or disordered regions, using techniques such as neutron spectroscopy. Many of the proteins studied have medical or biotechnological applications.
In addition to conducting research, Martin Weik teaches a master course on using X-ray and neutron scattering to study biomolecular structure and dynamics at the University of Parma, Italy. Between March and June 2026, he is a Fulbright–UGA Scholar, hosted by Professor Soichi Wakatsuki in the Department of Structural Biology at Stanford University. -
Katja Gabriele Weinacht, MD, PhD
Assistant Professor of Pediatrics (Stem Cell Transplantation and Regenerative Medicine)
Current Research and Scholarly InterestsPediatric Hematopoietic Stem Cell Transplantation
DiGeorge Syndrome
Genetic Immune Diseases
Immune Dysregulation -
Ann Weinacker
Professor of Medicine (Pulmonary and Critical Care)
Current Research and Scholarly InterestsDr. Weinacker's research interests center around ICU outcomes. Her specific interests include primary graft dysfunction in lung transplant recipients.
-
Alexis Thomas Weiner
Basic Life Research Scientist, Pathology Sponsored Projects
Current Research and Scholarly InterestsThe planar cell polarity (PCP) signaling pathway polarizes animal cells along an axis parallel to the tissue plane, and in so doing generates long-range organization that can span entire tissues. Although its core proteins and much about their interactions are known, how PCP signaling occurs at a mechanistic level remains fundamentally mysterious. In my current project I will employ novel genetic methods to dissect the logic underlying how cellular asymmetry arises at a molecular level.
-
Eva Weinlander
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsWomen's Health
Mind Body Medicine
Chronic Disease Management -
Ashira Weinreich
Masters Student in Community Health and Prevention Research, admitted Autumn 2025
BioAshira is a National Science Foundation Graduate Research Fellow (NSF-GRFP), completing her MS in Community Health and Prevention Research at Stanford University (2025 - June 2026), and a Community Engaged Scholar at Stanford's Haas Center for Public Service. Her research examines how diverse bio-cultural systems inform community health in times of sociocultural and ecological change. By linking cyclical patterns in health practices with seasonality, nutrient intake, and medicinal plant use, Ashira explores how village communities adapt to climatic and environmental variability. As a Fulbright Research Fellow in Nepal (2024-2025), Ashira interviewed community members, organized and facilitated workshops in 12 villages ranging in elevation from 6,500ft to 13,000ft, engaging over 200 villagers. She believes that anticipatory capacity is important in developing resilience in Nepal’s high-altitude Himalayan regions. Ashira is committed to a collaborative, community-centered approach to research, emphasizing the importance of reciprocity and giving back to the community.
-
Dana Weintraub
Member, Maternal & Child Health Research Institute (MCHRI)
Current Research and Scholarly InterestsResearch interests include: 1) Childhood obesity, community-based interventions to increase physical activity 2) Impact of medical-legal collaboration on child and family health.
-
Thomas G Weiser, MD, MPH
Clinical Professor, Surgery - General Surgery
BioDr. Thomas Weiser is a general, emergency, and trauma surgeon, and surgical intensivist. He treats and cares for injured patients and those with acute surgical emergencies as well as manages critically ill surgical patients in the Intensive Care Unit.
His research has focused on evaluating the role surgical care plays in the delivery of health services in resource poor settings, in particular low and middle income countries. He is interested in barriers to access and provision of surgical care, the quality of surgical services, and outcomes research as well as the science of implementation, how improvements can be made, and how to strengthen compliance with best practices and change behaviors for the better. He also has an interest in domestic policy as it relates to trauma outcomes, trauma systems, insurance coverage and costs of care, and firearm violence.
Dr. Weiser's efforts have led to improvements in the safety and reliability of surgical service, the quality of surgical care delivered globally, and improvements team dynamics, function, and communication. He works closely with Lifebox, a nonprofit focused on improving surgical and anesthetic safety worldwide, where he was previously the Consulting Medical Officer. Lifebox delivers programs throughout the world in combination with local partners and includes the procurement and distribution of low cost devices to improve the safety of care (including pulse oximeters for the routine monitoring of patients undergoing anesthesia and surgical headlights to safeguard care during power outage) and Clean Cut, a surgical infection prevention and control program that has reduced complications by up to 50%. This work safeguards millions of surgical patients every year.
From 2006-2009, he was part of the World Health Organization’s Safe Surgery Saves Lives program where he quantified the global volume of surgery and created, implemented, evaluated, and promoted the WHO Surgical Safety Checklist. He was part of the Lancet Commission on Global Surgery, the World Bank Disease Control Priorities Program, and a Gates Grand Challenge awardee.
From 2022-2026 he was the Program Director of Surgery: Assess/Validate/Expand (SAVE) at Wellcome Leap. His current research efforts aim to accelerate computer vision models for quantifying surgical performance and identifying mechanisms to predict patient recovery trajectories following surgery. -
Eric A Weiss, MD, FACEP
Professor of Emergency Medicine at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsMy focus of research is wilderness medicine, including hypothermia, heat illness, altitude illness, improvised medical care in austere environments and wound care. I also have a strong interest in Disaster Medicine, Travel Medicine and International Health, and Pandemics.
-
Eric L. Weiss, MD, DTM&H
Clinical Associate Professor, Emergency Medicine
Current Research and Scholarly InterestsIgnorance of Hepatitis A Among Travelers (writing up data).Travelers Neglecting to Seek Pre Travel Medicine Advice (writing up data).Fluoroquinolones in the Treatment of Complicated Urinary Tract Infections (new ED study)
-
Irving Weissman
Virginia & D.K. Ludwig Professor of Clinical Investigation in Cancer Research, Professor of Pathology, and of Developmental Biology
Current Research and Scholarly InterestsStem cell and cancer stem cell biology; development of T and B lymphocytes; cell-surface receptors for oncornaviruses in leukemia. Hematopoietic stem cells; Lymphocyte homing, lymphoma invasiveness and metastasis; order of events from hematopoietic stem cells [HSC] to AML leukemia stem cells and blood diseases, and parallels in other tissues; discovery of tumor and pathogenic cell 'don't eat me' and 'eat me' signals, and translation into therapeutics.
-
Chad S. Weldy, M.D., Ph.D.
Instructor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsAs a physician-scientist I work to understand the genetic basis of cardiovascular disease and the transcriptional and epigenomic mechanisms of atherosclerosis. My work is focused across four main areas of cardiovascular genetics and mechanisms of coronary artery disease and smooth muscle biology:
1.Vascular smooth muscle specific ADAR1 mediated RNA editing of double stranded RNA and activation of the double stranded RNA receptor MDA5 in coronary artery disease and vascular calcification
2.Defining on single cell resolution the cellular and epigenomic features of human vascular disease across vascular beds of differing embryonic origin
3.CRISPRi screening with targeted perturb seq (TAPseq) to identify novel CAD genes in human coronary artery smooth muscle cells
4.Investigation of the epigenetic and molecular basis of coronary artery disease and smooth muscle cell transition in mice with conditional smooth muscle genetic deletion of CAD genes Pdgfd and Sox9
My work is focused on discovery of causal mechanisms of disease through leveraging human genetics with sophisticated molecular biology, single cell sequencing technologies, and mouse models of disease. This work attempts to apply multiple scientific research arms to ultimately lead to novel understandings of vascular disease and discover important new therapeutic approaches for drug discovery.
First Author Manuscripts for this work:
•Weldy, C. S., et al. (2025). Smooth muscle cell expression of RNA editing enzyme ADAR1 controls activation of RNA sensor MDA5 in atherosclerosis. (2025). Nature Cardiovascular Research. 1-17, PMID: 40958051, doi: 10.1038/s44161-025-00710-5
•*Selected as finalist for Louis N. and Arnold M. Katz Basic Science Research Prize from the American Heart Association, finalist competition November 16, 2024, Chicago
•Work was highlighted in the Stanford Department of Medicine News
https://medicine.stanford.edu/news/current-news/standard-news/RNA-editing.html
•Weldy, C.S., et al. (2025). Epigenomic landscape of single vascular cells reflects developmental origin and disease risk loci. Molecular Systems Biology. 1-25, PMID: 40931195, doi:10.1038/s44320-025-00140-2.
•*Selected for the cover of November 2025 edition of Molecular Systems Biology
Grant funding received for this work:
Mentored Clinical Scientist Research Career Development Award (K08)(NIH/NHLBI, 1 K08 HL167699-01), August, 2023 – July 2028. PI: Weldy, Chad
•Title of proposal: “ADAR Mediated RNA editing is a causal mechanism in coronary artery disease”.
•Activated 08/01/2023
•$850,000 over 5 years
Career Development Award, American Heart Association (AHA CDA)(23CDA1042900), July, 2023 – June, 2026. PI: Weldy, Chad
•Title of proposal: “Linking RNA editing to coronary artery calcification and disease”
•Activated 07/01/2023
•$231,000 over three years
NIH Loan Repayment Program (LRP) Award (NIH/NHLBI) Renewal Award, July, 2023. PI: Weldy, Chad
•Title of proposal: “RNA editing is a causal mechanism of coronary artery disease”
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) (NIH/NHLBI, 1 F32 HL160067-01), July, 2021 – June 2023 (Completed). PI: Weldy, Chad
• Titled, “A transcriptional network which governs smooth muscle transition is mediated by causal coronary artery disease gene PDGFD”
•*Received perfect score with impact score 10, 1st percentile
NIH Loan Repayment Program (LRP) Award (NIH/NHLBI), July, 2021. PI: Weldy, Chad
•Title of proposal: "Single cell transcriptomic and epigenomic features of human atherosclerosis".
•This will award up to $100,000 towards student loans over the next 24 months with opportunity for renewal after 24 months. -
Andy Wen
Clinical Professor, Pediatrics - Critical Care
BioDr. Andy Y. Wen joined the Division of Pediatric Critical Care Medicine at Stanford University School of Medicine in 2019. He received his B.A. degree in Molecular Biology & Biochemistry at Rutgers University, and his medical degree from Rutgers Robert Wood Johnson Medical School. He completed a Pediatrics Residency Training Program at the State University of New York Downstate Medical Center and a Pediatric Critical Care Medicine Fellowship Training Program at the University of California Los Angeles.
After briefly working for Kaiser Permanente Southern California Permanente Medical Group, Dr. Wen joined the Division of Pediatric Critical Care at NYU School of Medicine. He assumed the role of Bellevue Hospital PICU medical director and helped to expand Bellevue's Pediatric Trauma Program and Pediatric Critical Care Transport Services for the New York City (NYC) public hospital system, NYC Health & Hospitals. During the 2014 to 2016 Ebola outbreak in West Africa, Dr. Wen was a member of the Special Pathogens Program at Bellevue Hospital, which was one of only four institutions in the US to treat a patient with Ebola and helped established the National Ebola Training and Education Center (NETEC).
While at UCLA, Dr. Wen received a T32 Training Grant to perform research investigating the role of transcription factor CREB in innate immune function using a murine model for AML. At NYU, his research projects included analyzing transfusion practices in the PICU, quality improvement projects targeting patients at high risk for unplanned extubation, and exploring the utility of NIRS as an early predictor of seizure activity. Dr. Wen is a member of Pediatric Acute Lung Injury & Sepsis Investigators (PALISI) and has been involved in multi-center studies looking at critical care patients with Bronchiolitis and COVID-19. Dr. Wen is the USA Editor for Journal of Pediatric Intensive Care and has reviewed abstracts for PAS, SCCM, and AMIA. His educational efforts have included teaching Pediatric Fundamental Critical Care Support (PFCCS) courses, helping develop a Pediatric Residency Simulation course curriculum, and helping develop a Point-of-Care Ultrasound course for critical care advanced practice providers.
At Stanford University School of Medicine, Dr. Wen is in charge of Regional Pediatric Critical Care Outreach with a goal to promote medical education and expand the Stanford Children’s Health network to improve access for sick children in need of high quality care. Dr. Wen provides clinical services at both John Muir Medical Center and Lucile Packard Children’s Hospital. -
Gerald Wen
IT Manager, Anesthesiology, Perioperative and Pain Medicine
Current Role at StanfordIT Manager
Tuesday/Thursday @ Redwood City Campus, Discovery Hall -
Paul Wender
Francis W. Bergstrom Professor and Professor, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsMolecular imaging, therapeutics, drug delivery, drug mode of action, synthesis
-
Kirsti Weng Elder MD/MPH
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Weng is the Section Chief of General Primary Care. She has over 25 years of experience caring for patients in primary care, urgent care and in the hospital. She is also a teacher of students and residents. As a leader in primary care re-design, she is passionate about practicing patient-centered medicine. She is a an advocate of Mindfulness Self-compassion to develop equanimity. She practices with an emphasis on musculoskeletal care as she feels fitness is the foundation of wellness. She is a leader in organizational change and physician management. She supports community health and care for the underserved. Outside of work she enjoys biking, reading and spending time with her 8 children.
-
Wen-Kai Weng, MD, PhD
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy) and, by courtesy, of Dermatology
On Partial Leave from 04/06/2026 To 06/12/2026Current Research and Scholarly InterestsMy research interest is on immunotherapy (including allogeneic transplant) of cancer. I have studies the mechanism of monoclonal antibody therapy in lymphoma patients and am currently working on designing new strategy to enhance the clinical efficacy of antibody therapy by infusing expanded NK cells. I am also interested in using tumor vaccine along with hematopoietic cell transplant.
-
Yingjie Weng
Assistant Director, Learning Health Systems Program, Med/Quantitative Sciences Unit
Current Role at StanfordResponsibilities - Assistant Director, Learning Health Systems Program (LHS)
Program Development & Resource Management
•Establish and update LHS program resources, including standard operating procedures, statistical analysis plan templates, and training materials.
Training & Mentorship
•Host onboarding training programs for new QSU hires and conduct regular training sessions within QSU.
•Establish and mentor a core team of statisticians and data scientists dedicated to the LHS program.
Project Oversight & Strategy
•Guide project assignments related to quality improvement, pragmatic trials, and real-world evidence studies utilizing electronic health records (EHRs).
Collaboration & Relationship Management
•Maintain strong partnerships with clinical advocates of LHS projects across collaborating departments.
•Host onboarding sessions with department leaders to communicate the program’s mission and objectives.
•Establish collaborations with various data teams across campus
Education & Outreach
•Organize educational sessions and lectures for clinical investigators across partnering departments.
•Serve as the primary point of contact for QSU regarding the LHS program.
--------------------------------------------------------------------------------------------------------------------------------
Responsibilities - Senior Biostatistician
Scientific Collaboration & Research Support
•Partner with research investigators on a wide range of scientific studies across the School of Medicine and Stanford Healthcare system.
Study Design & Statistical Planning
•Lead the development of study protocols and statistical analysis plans.
Data Management & Analysis
•Perform data management, visualization, and statistical analysis using advanced methodologies and tools.
Results Interpretation & Reporting
•Interpret statistical results and translate findings into clear, domain-specific language for publications and reports.
Grant & Manuscript Development
•Lead statistical methodology and results sections for grant applications, manuscript submissions, and public health reports.
Methodological Research
•Conduct research on statistical methodologies to enhance study designs and analytical approaches.
Mentorship & Teaching
•Mentor junior statisticians and serve as a KL2 research methodology mentor.
•Deliver lectures, including presentations for Hospital Medicine Grand Rounds. -
Gerlinde Wernig
Associate Professor of Pathology
Current Research and Scholarly InterestsFibrotic diseases kill more people than cancer in this country and worldwide. We believe that scar-forming cells called fibroblasts are at the core of the fibrotic response in parenchymal organ fibrosis in the lung, liver, skin, bone marrow and tumor stroma. At the cellular level we think of fibrosis as a step wise process which implicates inflammation and fibrosis. We seek to identify new effective immune therapy targets to treat fibrotic diseases.
-
Marius Wernig
Professor of Pathology and, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsEpigenetic Reprogramming, Direct conversion of fibroblasts into neurons, Pluripotent Stem Cells, Neural Differentiation: implications in development and regenerative medicine
-
Philipp Wesp
Postdoctoral Scholar, Radiology
BioI am a postdoctoral researcher investigating interpretable machine learning (ML) and large language model (LLM) applications in clinical radiology. My current research focuses on two complementary areas: understanding what human-interpretable concepts self-supervised vision foundation models learn through mechanistic interpretability techniques like sparse autoencoders, and developing LLM-based systems, including agentic workflows and retrieval augmented generation (RAG) architectures, that leverage unstructured hospital data to improve radiological workflows. I earned my PhD from LMU Munich, where I focused on clinically motivated machine learning applications in medical imaging in the Department of Radiology.
My work is partially funded by a Walter Benjamin Fellowship from the DFG (German Research Foundation). -
Dee W. West
Professor of Health Research and Policy, Emeritus
Current Research and Scholarly Interests- Cancer etiology (diet, familial, genetic), especially breast, prostate and colon cancer
- Cancer surveillance (Cancer registration, cancer patterns)
- Cancer outcomes (Survival, quality of life, quality of care) -
Robert West
Sabine Kohler, MD, Professor of Pathology
Current Research and Scholarly InterestsRob West, MD, PhD, is a Professor of Pathology at Stanford University Medical Center. He is a clinician scientist with experience in translational genomics research to identify new prognostic and therapeutic markers in cancer. His research focus is on the progression of neoplasia to carcinoma. His lab has developed spatially oriented in situ methods to study archival specimens. He also serves as a surgical pathologist specializing in breast pathology.
-
Lynn Marie Westphal, M.D.
Professor of Obstetrics and Gynecology (Reproductive Endocrinology and Infertility) at Stanford University Medical Center, Emerita
Current Research and Scholarly InterestsInfertility, fertility preservation, oocyte cryopreservation
-
Cornelia Weyand
Professor of Medicine (Immunology and Rheumatology), Emerita
Current Research and Scholarly InterestsAutoimmunity
Chronic inflammatory disease
Metabolic control of immune function
